FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

MACNEILL PHILIP

2. Date of Event Requiring Statement (MM/DD/YYYY)
5/1/2015 

3. Issuer Name and Ticker or Trading Symbol

PHARMATHENE, INC [PIP]

(Last)        (First)        (Middle)

C/O PHARMATHENE, INC., ONE, PARK PLACE, SUITE 450

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
CFO /

(Street)

ANNAPOLIS, MD 21401       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value $0.0001 per share   25000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Purchase Option     (1) 1/31/2021   Common Stock   15000   $3.23   D    
Stock Purchase Option     (2) 12/1/2021   Common Stock   1845   $1.21   D    
Stock Purchase Option     (3) 12/1/2021   Common Stock   4500   $1.21   D    
Stock Purchase Option     (4) 12/3/2022   Common Stock   5625   $1.13   D    
Stock Purchase Option     (5) 1/29/2024   Common Stock   18750   $1.94   D    
Stock Purchase Option     (6) 12/8/2024   Common Stock   20000   $1.71   D    

Explanation of Responses:
( 1)  These options became exercisable in 4 equal annual installments, with the first installment exercisable on January 31, 2011.
( 2)  These options became exercisable on December 1, 2012.
( 3)  These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 1, 2011.
( 4)  These options are exercisable in 4 equal annual installments, with the first installment exercisable on December 3, 2012.
( 5)  These options are exercisable in 4 equal annual installments, with the first installment exercisable on January 29, 2014.
( 6)  These options are exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2014.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
MACNEILL PHILIP
C/O PHARMATHENE, INC., ONE
PARK PLACE, SUITE 450
ANNAPOLIS, MD 21401

CFO

Signatures
/s/ Philip MacNeill 5/5/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Pharmathene, (delisted) (AMEX:PIP)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Pharmathene, (delisted) Charts.
Pharmathene, (delisted) (AMEX:PIP)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Pharmathene, (delisted) Charts.